{"id":"https://openalex.org/W4361920439","doi":"https://doi.org/10.1158/1078-0432.22462023","title":"Supplementary materials and methods untracked from A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers","display_name":"Supplementary materials and methods untracked from A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361920439","doi":"https://doi.org/10.1158/1078-0432.22462023"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22462023","doi":"https://doi.org/10.1158/1078-0432.22462023","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22462023","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22462023","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087856756","display_name":"Georg Karpel\u2010Massler","orcid":"https://orcid.org/0000-0001-8236-5369","observed_orcids":["https://orcid.org/0000-0001-8236-5369"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Georg Karpel-Massler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067723604","display_name":"Basil A. J. Horst","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Basil A. Horst","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100723539","display_name":"Chang Shu","orcid":"https://orcid.org/0000-0001-5619-0294","observed_orcids":["https://orcid.org/0000-0001-5619-0294"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chang Shu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Lily Chau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lily Chau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051488803","display_name":"Takashi Tsujiuchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Takashi Tsujiuchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055848888","display_name":"Jeffrey N. Bruce","orcid":"https://orcid.org/0000-0002-6844-0286","observed_orcids":["https://orcid.org/0000-0002-6844-0286"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeffrey N. Bruce","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046673359","display_name":"Peter Canoll","orcid":"https://orcid.org/0000-0002-7001-0226","observed_orcids":["https://orcid.org/0000-0002-7001-0226"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Canoll","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050331720","display_name":"Lloyd A. Greene","orcid":"https://orcid.org/0000-0002-3225-5521","observed_orcids":["https://orcid.org/0000-0002-3225-5521"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lloyd A. Greene","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003019947","display_name":"James M. Angelastro","orcid":"https://orcid.org/0000-0001-5612-1221","observed_orcids":["https://orcid.org/0000-0001-5612-1221"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James M. Angelastro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5019896041","display_name":"Markus David Siegelin","orcid":"https://orcid.org/0000-0001-7113-3634","observed_orcids":["https://orcid.org/0000-0001-7113-3634"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Markus D. Siegelin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.34200000762939453,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.34200000762939453,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.10270000249147415,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.06539999693632126,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atf5","display_name":"ATF5","score":0.9789999723434448},{"id":"https://openalex.org/keywords/cell-penetrating-peptides","display_name":"cell-penetrating peptides","score":0.9610000252723694},{"id":"https://openalex.org/keywords/synthetic-peptides","display_name":"synthetic peptides","score":0.8230000138282776},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8849999904632568},{"id":"https://openalex.org/keywords/refractory-cancer","display_name":"refractory cancer","score":0.8019999861717224},{"id":"https://openalex.org/keywords/transcription-factor-inhibition","display_name":"transcription factor inhibition","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C3020442560","wikidata":"https://www.wikidata.org/wiki/Q4971815","display_name":"Broad spectrum","level":2,"score":0.5781885981559753},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.5387168526649475},{"id":"https://openalex.org/C2776929087","wikidata":"https://www.wikidata.org/wiki/Q189096","display_name":"Cell-penetrating peptide","level":3,"score":0.5304253101348877},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4787846803665161},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.27808332443237305},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.277718722820282},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.24428746104240417},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16031479835510254}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1078-0432.22462023","doi":"https://doi.org/10.1158/1078-0432.22462023","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22462023","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.22462023.v1","doi":"https://doi.org/10.1158/1078-0432.22462023.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22462023.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22462023","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_materials_and_methods_untracked_from_A_Synthetic_Cell-Penetrating_Dominant-Negative_ATF5_Peptide_Exerts_Anticancer_Activity_against_a_Broad_Spectrum_of_Treatment-Resistant_Cancers/22462023","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22462023","doi":"https://doi.org/10.1158/1078-0432.22462023","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22462023","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361945487","https://openalex.org/W2344125583","https://openalex.org/W2625891800","https://openalex.org/W2561440114","https://openalex.org/W7128445061","https://openalex.org/W2741695289","https://openalex.org/W2560679504","https://openalex.org/W2802506518","https://openalex.org/W2802562217","https://openalex.org/W7160126457"],"abstract_inverted_index":{"Supplementary":[0],"materials":[1],"and":[2],"methods":[3],"untracked":[4]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}